The U.S.'s 1,000,000 diabetics have had high hopes for two drugs that, taken by mouth, might free them from daily injections of insulin (TIME, Feb. 27). Last week the reports were mixed.
¶Indianapolis' Eli Lilly & Co., makers of carbutamide (originally known as BZ-55), warned doctors that among an estimated 1,000 patients who have received carbutamide in the last 18 months there have been eight deaths for which the drug may have been at least partly responsible. There was yet no proof that carbutamide was solely to blame but Lilly was putting doctors on guard. About 5% of patients had skin rashes,...
To continue reading:
or
Log-In
